Recruiting
Phase 2

Bezuclastinib & Sunitinib

Sponsor:

Sarcoma Alliance for Research through Collaboration

Code:

NCT06208748

Conditions

Gastrointestinal Stromal Tumors

GIST

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Bezuclastinib in combination with sunitinib

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-04-19. This information was provided to ClinicalTrials.gov by Sarcoma Alliance for Research through Collaboration on 2025-01-31.